Anonymous v Bayer: BJMA ‘Annual Scientific Meeting’ sponsorship ruled mainly social, not primarily educational (AUTH/2631/8/13)

📅 2013 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2631/8/13
PartiesAnonymous v Bayer
IssueSponsorship of a meeting (BJMA UK annual meeting, Bolton, July 2013)
Applicable Code year2012
Complaint received7 August 2013
Case completed25 October 2013
AppealNo appeal
Bayer involvement£1,000 exhibition stand; sponsored a speaker; briefed speaker; provided approved slide set
Panel view of meetingMainly social/cultural; maximum scientific content just over three hours across two days
Breach clausesClause 2; Clause 9.1; Clause 19.1
No breach clausesClause 22.1; Clause 22.2
SanctionsUndertaking received; Advertisement

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • An anonymous complainant alleged the BJMA UK annual meeting (Bolton, July 2013) was more of a weekend family/social gathering than a fully educational meeting, with children’s activities and entertainment (eg children’s football, “BJMA’s Got Talent”).
  • The complainant also alleged companies should not have sponsored the event or had promotional stands in front of the public.
  • Bayer sponsored what it believed was an independent third-party scientific meeting, paying £1,000 for an exhibition stand and providing a speaker on “The changing face of Anticoagulation in Primary Care: new solutions to old problems”.
  • Bayer briefed the speaker and provided an approved slide set for use on the day.
  • The Panel reviewed agendas and supporting documents and concluded the meeting’s main purpose appeared social/cultural, with a maximum scientific content of just over three hours across two days.
  • The Panel considered company involvement (sponsoring speakers and paying for exhibition space) created an unacceptable impression, especially given meeting documentation highlighting social/entertainment elements.
  • On the allegation of promotion to the public, the Panel noted submissions that only registered delegates accessed the exhibition area; the complainant provided no supporting detail and did not discharge the burden of proof.
⚖️

Outcome

  • Breach of Clause 19.1 (meeting not primarily educational / did not meet Code requirements for meetings).
  • Breach of Clause 9.1 (high standards not maintained).
  • Breach of Clause 2 (conduct brought discredit upon and reduced confidence in the industry; used as a sign of particular censure).
  • No breach of Clause 22.1 and Clause 22.2 (alleged promotion to the public not proven on the balance of probabilities).
  • No appeal (for Bayer’s case).
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training